Molecular profiling of childhood cancer: Biomarkers and novel therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular profiling of childhood cancer: Biomarkers and novel therapies

Published:2014-06 Issue: Volume:1 Page:59-77
ISSN:2214-6474
Container-title:BBA Clinical
language:en
Short-container-title:BBA Clinical

Author:

Saletta Federica,Wadham Carol,Ziegler David S.,Marshall Glenn M.,Haber Michelle,McCowage Geoffrey,Norris Murray D.,Byrne Jennifer A.

Publisher

Elsevier BV

Subject

Physiology (medical),Molecular Medicine,Pathology and Forensic Medicine

Reference329 articles.

1. Cancer Facts & Figs. 2014;American Cancer Society,2014

2. Cancer treatment and survivorship statistics, 2012;Siegel;CA Cancer J. Clin.,2012

3. Emerging treatments and gene expression profiling in high-risk medulloblastoma;Sardi;Paediatr. Drugs,2007

4. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments;Owens;Crit. Rev. Clin. Lab. Sci.,2012

5. Advances in the genetics of high-risk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy;Loh;Clin. Cancer Res.,2012

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling;Journal of Molecular Histology;2024-01-02

2. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario;Pharmaceutics;2023-02-16

3. Biomarkers and Corresponding Biosensors for Childhood Cancer Diagnostics;Sensors;2023-01-28

4. A Chemo-Genomic Approach Identifies Diverse Epigenetic Therapeutic Vulnerabilities in MYCN-Amplified Neuroblastoma;Frontiers in Cell and Developmental Biology;2021-04-21

5. Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin;British Journal of Cancer;2021-04-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3